Scholars Central

Short communicationPublished 26 Oct 2019

A case report series study for the effects of Policosanol on Post-Stroke Cognitive Impairment

Authors: Javier Sanchez, Trujillo C

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Ischemic stroke may be a leading explanation for disability, including post-stroke cognitive impairment (CI), that no effective therapy is out there. Post-stroke patients are managed with antiplatelet drugs, and antihypertensive, hypoglycemic and/or cholesterol-lowering drugs, as needed. Policosanol is an antiplatelet and cholesterol lowering agent. Studies done before are demonstrated that adding policosanol to aspirin (AS) therapy improves post-stroke neurological recovery compared to placebo + AS.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Neurodegenerative Diseases and Disorders
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Javier Sanchez”
  • BylineArticles whose byline prints “Trujillo C”